Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      New USFDA Generic Guidelines to help Indian Pharma Companies in Submitting ANDAs

      New USFDA Generic Guidelines to help Indian Pharma Companies in Submitting ANDAs

      Medical Dialogues Bureau29 Oct 2018 4:23 PM IST
      New Delhi: A weekend report by India Ratings has declared that the recent guidance from the US Food & Drug Administration (USFDA) on complex...
      Cipla gets USFDA approval for Hypertension, Cardiac drug

      Cipla gets USFDA approval for Hypertension, Cardiac drug

      Medical Dialogues Bureau29 Oct 2018 10:00 AM IST
      NEW DELHI: Pharmaceutical giant Cipla has recently announced that it has received final approval from the US health regulator to market Metoprolol...
      Big Pharma Companies to Return to Double-Digit Growth this Fiscal: Crisil

      Big Pharma Companies to Return to Double-Digit Growth this Fiscal: Crisil

      Medical Dialogues Bureau29 Oct 2018 9:45 AM IST
      Domestic revenues of big pharma companies are expected to grow 12-13 per cent this fiscal, given better access to healthcare and deeper penetration of...
      Novartis, Pfizer Team up to develop drugs for liver disease treatment

      Novartis, Pfizer Team up to develop drugs for liver disease treatment

      Medical Dialogues Bureau29 Oct 2018 9:30 AM IST
      ZURICH/NEW YORK: Novartis AG and Pfizer Inc are joining forces to develop treatments for a liver disease many drug companies believe will become a...
      Eye Disease Market Primed for Shake-up: Roche touts study data of experimental Antibody Faricimab

      Eye Disease Market Primed for Shake-up: Roche touts study data of experimental Antibody Faricimab

      Medical Dialogues Bureau29 Oct 2018 9:00 AM IST
      ZURICH: Swiss drugmaker Roche has touted data for a new drug against a blindness-causing eye disease that hits millions of older people, the latest...
      Delhi court issues notices to Sterling Biotech owners in Rs 8,100 crore bank loan fraud case

      Delhi court issues notices to Sterling Biotech owners in Rs 8,100 crore bank loan fraud case

      Medical Dialogues Bureau28 Oct 2018 10:54 AM IST
      New Delhi: A Delhi court has sought a response from Sterling Biotech promoters following an Enforcement Directorate's plea to declare them fugitive...
      BRS Venture Plans to invest Rs 2193 crore to acquire Indian Hospitals

      BRS Venture Plans to invest Rs 2193 crore to acquire Indian Hospitals

      Medical Dialogues Bureau28 Oct 2018 9:15 AM IST
      New Delhi: The UAE-based USD 3 billion BRS Ventures plans to acquire hospitals in India, as it looks to consolidate its healthcare practice. BRS...
      Merck says to retain animal health business as part of company

      Merck says to retain animal health business as part of company

      Medical Dialogues Bureau28 Oct 2018 9:05 AM IST
      New Delhi: Merck & Co Inc has recently indicated that it would keep its animal health business as part of the company, in response to questions...
      Boston Scientific beats profit estimates on surgical business strength

      Boston Scientific beats profit estimates on surgical business strength

      Medical Dialogues Bureau28 Oct 2018 9:00 AM IST
      New Delhi: Medical Device Boston Scientific Corp posted a slightly better-than-expected quarterly profit on Wednesday, helped by strength in its...
      Sun Pharma launches psoriasis treatment drug Ilumya in US

      Sun Pharma launches psoriasis treatment drug Ilumya in US

      Medical Dialogues Bureau27 Oct 2018 2:09 PM IST
      New Delhi: Sun pharmaceutical has recently launched its plaque psoriasis treatment drug Ilumya in the US market. Ilumya in the strength of 100 mg/mL...
      Glenmark gets USFDA approval for Fluocinolone Acetonide Topical Oil

      Glenmark gets USFDA approval for Fluocinolone Acetonide Topical Oil

      Medical Dialogues Bureau27 Oct 2018 11:36 AM IST
      Mumbai: Glenmark Pharmaceuticals Inc. has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Fluocinolone...
      Alembic Pharma Q2 profit up 64 percent to Rs 200 crore

      Alembic Pharma Q2 profit up 64 percent to Rs 200 crore

      Medical Dialogues Bureau27 Oct 2018 10:10 AM IST
      New Delhi: Alembic Pharmaceutical has reported 64.58 per cent rise in consolidated net profit to Rs 200.07 crore for the quarter ended September 30,...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok